🇺🇸 VTRS — Viatris Inc.

Healthcare
← Volver

Precio actual

16,88 USD

Máx. histórico

76,69

4151 días

Split 3:2 del 09/10/2003

Caída desde máximo

-77,99%

Rango 52 semanas

9,43 – 18,39

Variación hoy

-0,35%

Cierre anterior

16,94

Rango de hoy

16,67 – 17,02

Volumen hoy

5.732.791

Información
Nombre completo
Viatris Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Healthcare
Industria
Drug Manufacturers - Specialty & Generic
Empleados
30.000
PER ⓘ
—
Dividend yield
2,84% (puede no estar actualizado)
Precio objetivo analistas
18,50 USD (puede no estar actualizado)
Primera cotización
17/03/1980
Precio actualizado
hace 3 días
Sobre la empresa

Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and biosimilars. It also provides drugs in various therapeutic areas covering various noncommunicable and infectious diseases, including cardiovascular, CNS and anesthesia, dermatology, diabetes and metabolism, eye care, gastroenterology, immunology, oncology, and respiratory and allergy, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. In addition, the company offers medicines in the form of oral solid doses, injectables, and complex dosage forms to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. It distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies under the Lyrica, Lipitor, Celebrex, Viagra, Creon, Influvac, Wixela Inhub, EpiPen Auto-Injector, Fraxiparine, Yupelri, Norvasc, Amitiza, Effexor, Lipacreon, Zoloft, Xalabrands, Dymista, Xanax, and Breyna brands. The company has collaboration agreements with Mapi Pharma Ltd. to develop and commercialize long-acting glatiramer acetate depot products and additional products; Revance Therapeutics, Inc. to develop, manufacture, and commercialize a biosimilar to the branded biologic product, BOTOX; and Theravance Biopharma, Inc. to develop and commercialize revefenacin. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.

Dividendos repartidos Total últimos 12 meses: 0,4800 USD · Yield: 2,84%
Fecha de pago Importe por participación
22/11/2022 0,1200 USD
23/08/2022 0,1200 USD
23/05/2022 0,1200 USD
23/02/2022 0,1200 USD
22/11/2021 0,1100 USD
23/08/2021 0,1100 USD
21/05/2021 0,1100 USD
27/06/2007 0,0600 USD
28/03/2007 0,0600 USD
27/12/2006 0,0600 USD
27/09/2006 0,0600 USD
28/06/2006 0,0600 USD
29/03/2006 0,0600 USD
28/12/2005 0,0600 USD
28/09/2005 0,0600 USD
Splits Registrados en el histórico de precios
Fecha Ratio
09/10/2003 3:2
28/01/2003 3:2
16/08/1995 3:2
03/08/1992 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
05/12/1997 10,08 10,17 9,86 9,92 -2,19% 3,03% 1.066.050
04/12/1997 10,22 10,25 10,08 10,14 +0,00% 1,63% 609.075
03/12/1997 10,08 10,19 10,06 10,14 -0,27% 1,38% 410.175
02/12/1997 10,14 10,25 10,00 10,17 +1,39% 2,47% 574.875
01/12/1997 9,92 10,17 9,86 10,03 +1,69% 3,08% 1.132.425
28/11/1997 9,89 10,00 9,83 9,86 +0,00% 1,69% 342.675
26/11/1997 10,11 10,11 9,83 9,86 -3,27% 2,75% 1.862.775
25/11/1997 10,36 10,36 10,19 10,19 -1,61% 1,61% 1.464.975
24/11/1997 10,31 10,39 10,17 10,36 +0,54% 2,16% 1.217.250
21/11/1997 10,33 10,42 10,25 10,31 -0,27% 1,61% 1.375.650
20/11/1997 10,08 10,33 10,08 10,33 +2,20% 2,48% 806.850
19/11/1997 10,17 10,22 10,03 10,11 -1,62% 1,91% 746.100
18/11/1997 10,39 10,44 10,22 10,28 -0,80% 2,14% 831.825
17/11/1997 10,67 10,67 10,36 10,36 -2,86% 2,86% 668.925
14/11/1997 10,33 10,67 10,31 10,67 +3,50% 3,49% 1.355.625
13/11/1997 10,58 10,58 10,28 10,31 -2,37% 2,89% 1.138.500
12/11/1997 10,61 10,67 10,50 10,56 -0,52% 1,57% 971.325
11/11/1997 10,83 10,86 10,56 10,61 +0,00% 2,82% 1.298.475
10/11/1997 10,89 10,89 10,58 10,61 +3,80% 2,81% 1.557.675
07/11/1997 10,33 10,42 10,22 10,22 -3,41% 1,88% 1.292.175
06/11/1997 10,89 10,89 10,53 10,58 -0,26% 3,32% 1.416.375
05/11/1997 10,25 10,78 10,25 10,61 +4,95% 5,15% 2.370.375
04/11/1997 9,97 10,14 9,81 10,11 +1,11% 3,34% 882.000
03/11/1997 9,78 10,06 9,72 10,00 +2,86% 3,41% 1.034.550
31/10/1997 9,67 9,86 9,56 9,72 +0,57% 3,16% 765.675
30/10/1997 9,78 9,94 9,53 9,67 -2,25% 4,26% 754.425
29/10/1997 10,28 10,36 9,83 9,89 -3,26% 5,14% 936.000
28/10/1997 8,47 10,28 8,47 10,22 +6,67% 21,31% 2.883.150
27/10/1997 10,50 10,50 9,58 9,58 -9,69% 8,73% 1.977.750
24/10/1997 10,78 10,86 10,61 10,61 -1,55% 2,32% 843.750